Drug :: APhA applauds FDA’s decision about Behind the Counter class of drugs
The American Pharmacists Association (APhA) applauds the Food and Drug Administration’s (FDA) recent decision to consider the development of a behind the counter (BTC) class of drugs that could include medications available without a prescription and would also require the intervention of a pharmacist before dispensing.